I-Apixaban Intermediate CAS 503615-03-0 3-Morpholino-1-(4-Nitrophenyl)-5,6-Dihydropyridin-2(1H)-one Purity ≥99.0% (HPLC)

Incazelo emfushane:

3-Morpholino-1-(4-Nitrophenyl)-5,6-Dihydropyridin-2(1H)-one

I-CAS: 503615-03-0

Ubumsulwa: ≥99.0% (HPLC)

Ukubukeka: Impushana Ephuzi

I-Intermediate ye-Apixaban (CAS: 503612-47-3)

Thintana: UDkt. Alvin Huang

Iselula/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Ruifu Chemical ingumkhiqizi ohamba phambili we-3-Morpholino-1-(4-Nitrophenyl)-5,6-Dihydropyridin-2(1H)-one (CAS: 503615-03-0) enekhwalithi ephezulu.I-Ruifu Chemical inganikeza ukulethwa komhlaba wonke, intengo encintisanayo, isevisi enhle kakhulu, amanani amancane kanye nenqwaba etholakalayo.Thenga i-Apixaban intermediates,Please contact: alvin@ruifuchem.com

I-Apixaban Intermediates:

Chemical Properties:

Igama Lekhemikhali 3-Morpholino-1-(4-Nitrophenyl)-5,6-Dihydropyridin-2(1H)-one
Omqondofana 3-(4-Morpholinyl) -1-(4-Nitrophenyl)-5,6-Dihydro-2(1H)-Pyridinone;5,6-Dihydro-3- (4-Morpholinyl) -1- (4-Nitrophenyl) -2 (1H)-Pyridinone;I-Apixaban Ephakathi 3;Ukungcola kwe-Apixaban 36;Inqubo ye-Apixaban Ukungcola 1
Isimo Sesitoko Ku-Stock, Commercial Production
Inombolo ye-CAS 503615-03-0
I-Molecular Formula I-C15H17N3O4
Isisindo samangqamuzana 303.31 g/mol
I-Melting Point 165.0 ~ 170.0℃
Iphuzu elibilayo 506.5±50.0℃
Ukuminyana 1.357g/mL
I-COA ne-MSDS Iyatholakala
Umsuka Shanghai, China
Isigaba I-Intermediate ye-Apixaban (CAS: 503612-47-3)
Ibhrendi I-Ruifu Chemical

Imininingwane:

Izinto Amazinga Wokuhlola Imiphumela
Ukubukeka Impushana Ephuzi Impushana Ephuzi
I-Melting Point 165.0 ~ 170.0℃ 167.0 ~ 170.0℃
Ukulahlekelwa Ekumisweni ≤0.50% 0.3%
Ukungcola Komuntu Ngamunye (Ubukhulu.) ≤0.50% 0.3%
Ukungcola Okuphelele ≤1.00% 0.6%
Ukuhlanzeka / Indlela Yokuhlaziya ≥99.0% (HPLC) 99.4%
1 H NMR Spectrum Ihambisana Nesakhiwo Iyahambisana
LC/MS Ihambisana Nesakhiwo Iyahambisana
Isiphetho Umkhiqizo uhloliwe futhi uthobelana nemibandela enikeziwe

Iphakheji/Isitoreji/Ukuthumela ngomkhumbi:

Iphakheji:Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina isiqukathi sivalwe ngokuqinile futhi usigcine endaweni epholile, eyomile (2~8℃) nengena umoya omuhle kude nezinto ezingahambelani.Vikela ekukhanyeni nakumswakama.
Ukuthumela:Zilethe emhlabeni wonke ngendiza, yi-FedEx/DHL Express.Nikeza ukulethwa okusheshayo nokuthembekile.

503615-03-0 - Umzila Wokwenziwa:

www.ruifuchemical.com

Izinzuzo:

Amandla Anele: Izinsiza ezanele kanye nochwepheshe

Isevisi Yobuchwepheshe: Isevisi yokuthenga yokuma eyodwa

Iphakheji le-OEM: Iphakheji yangokwezifiso kanye nelebula iyatholakala

Ukulethwa Okusheshayo: Uma kungaphakathi kwesitoko, ukulethwa kwezinsuku ezintathu kuqinisekisiwe

Impahla Ezinzile: Gcina isitoko esinengqondo

Ukusekelwa Kwezobuchwepheshe: Isixazululo sezobuchwepheshe siyatholakala

Isevisi Yokuhlanganisa Ngokwezifiso: Isukela kumagremu kuye kumakhilo

Ikhwalithi Ephezulu: Kusungulwe uhlelo oluphelele lokuqinisekisa ikhwalithi

I-FAQ:

Indlela Yokuthenga?Sicela uxhumaneDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

Iminyaka engu-15 Yokuhlangenwe nakho?Sinesipiliyoni seminyaka engaphezu kwe-15 ekwakhiweni nasekuthumeleni kwamanye amazwe uhla olubanzi lwezinga eliphezulu lokuxhumanisa imithi noma amakhemikhali amahle.

Izimakethe Eziyinhloko?Thengisa emakethe yasekhaya, eNyakatho Melika, eYurophu, eNdiya, eKorea, eJapane, e-Australia, njll.

Izinzuzo?Ikhwalithi ephezulu, intengo ethengekayo, izinsizakalo ezichwepheshile nokusekelwa kobuchwepheshe, ukulethwa okusheshayo.

IkhwalithiIsiqiniseko?Isistimu yokulawula ikhwalithi eqinile.Imishini yobuchwepheshe yokuhlaziya ifaka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, NOMA, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njll.

Amasampula?Imikhiqizo eminingi inikeza amasampula wamahhala wokuhlolwa kwekhwalithi, izindleko zokuthumela kufanele zikhokhelwe amakhasimende.

Ukuhlolwa Kwemboni?Wamukelekile ekucwaningweni kwemboni.Sicela wenze i-aphoyintimenti kusengaphambili.

I-MOQ?Ayikho i-MOQ.I-oda elincane liyamukeleka.

Isikhathi sokuthumela? Uma kungaphakathi kwesitoko, ukulethwa kwezinsuku ezintathu kuqinisekisiwe.

Ezokuthutha?By Express (FedEx, DHL), by Air, by Sea.

Amadokhumenti?Ngemuva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njll.

Custom Synthesis?Ingahlinzeka ngezinsizakalo zokwenziwa ngokwezifiso ukuze zilingane kangcono nezidingo zakho zocwaningo.

Imigomo Yokukhokha?I-invoyisi ye-Proforma izothunyelwa kuqala ngemva kokuqinisekiswa kwe-oda, kufakwe nemininingwane yethu yasebhange.Inkokhelo nge-T/T (Telex Transfer), PayPal, Western Union, njll.

Isicelo:

I-3-Morpholino-1- (4-Nitrophenyl)-5,6-Dihydropyridin-2(1H)-one (CAS: 503615-03-0) iphakathi kokuhlanganisa kwe-Apixaban (CAS: 503612-47-3) .
I-Apixaban iwuhlobo olusha lwe-oral Xa factor inhibitor eyakhiwe ngokuhlanganyela yiBristol-Myers Squibb kanye nePfizer.Igama lokuhweba i-Eratol, okuwuhlobo olusha lwe-anticoagulant yomlomo.Ngokuvimbela i-coagulation factor ebalulekile Xa, i-Apixaban ingavimbela ukukhiqizwa kwe-thrombin kanye ne-thrombosis.
Ngomhla zingama-26 kuMbasa, 2007, uBristol-Myers Squibb wahlanganyela nePfizer ukumemezela ukubambisana ekuthuthukisweni kwe-anticoagulant yomlomo entsha i-Apixaban ephethwe yiBristol-Myers Squibb njengendlela ethuthukisiwe ye-warfarin.Ngokwesivumelwano sokubambisana, i-Pfizer izokhokha inkokhelo kusengaphambili engu-US $0.25 billion kuBristol-Myers Squibb ukuze ithwale u-60% wezindleko eziphelele zokuthuthukiswa kwe-anticoagulant Apixaban (ezoqaliswa kusukela ngoJanuwari 1, 2007), kuyilapho iBristol-Myers. I-squibb izothwala u-40% osele, ngaleyo ndlela ithole ilungelo lokuthuthukisa ngokuhlanganyela nokuthengisa umuthi.
Ngo-May 2011, i-Apixaban yaba ngowokuqala ukugunyaza ukuvinjelwa kwe-venous thrombosis ezigulini ezikhulile ezenza ukuhlinzwa okukhethiwe kwe-hip noma idolo emazweni e-27 EU, e-Iceland naseNorway.
Ngomhla ka-20 Novemba 2012, i-European Commission igunyaze i-Ererto (Apixaban) yokuvimbela isifo sohlangothi kanye ne-systemic embolism ezigulini ezikhulile ezine-non-valvular atrial fibrillation (NVAF) enesici esisodwa noma ngaphezulu engozini.Kamuva, i-Canadian Food and Drug Administration, Japan, kanye ne-US FDA igunyaze i-Ererto (Apixaban) yokuvimbela isifo sohlangothi kanye ne-systemic embolism ezigulini ezikhulile ezine-non-valvular atrial fibrillation (NVAF) enesici esisodwa noma ngaphezulu engozini.
Ngo-Ephreli 12, 2013, umuthi omusha we-anticoagulant Eloto (ELIQUIS)(apixaban) owakhiwe ngokuhlanganyela yiBristol-Myers Squibb kanye noPfizer wamenyezelwa ngokusemthethweni ukuthi uzofakwa ohlwini e-China.I-Ererto iyinoveli ye-oral factor Xa inhibitor yokuvimbela i-venous thromboembolism (VTE) ezigulini ezikhulile ezithatha indawo ye-hip noma yamadolo.Ukufakwa ohlwini kunikeza ukhetho olusha oluphephile nolusebenzayo lwe-anticoagulation yomtholampilo ngemva kokuhlinzwa kwamathambo, futhi kuletha izindaba ezinhle ezigulini zaseShayina ezishintshwa ngokukhethwa kwe-hip/edolo.Ucwaningo lwezokwelapha luye lwaqinisekisa ukuthi uma kuqhathaniswa ne-40mg enoxaparin kanye ngosuku, izikhathi ezi-2 ngosuku ukuphathwa komlomo kwe-Eratol (Apixaban) i-2.5mg iphumelela kakhulu ekuvimbeleni i-venous thromboembolism ngemva kokuhlinzwa esikhundleni se-hip noma idolo, futhi ayinyusi ingozi yokopha.

Bhala umyalezo wakho lapha futhi usithumelele wona